Evidence map›Paper›PMID 32438483›Full record

Trial reportEuropean journal of heart failure2020

Telemonitoring versus standard care in heart failure: a randomised multicentre trial.

Michel Galinier, François Roubille, Philippe Berdague, Gilles Brierre, Philippe Cantie, Patrick Dary, Jean-Marc Ferradou, Olivier Fondard, Jean Philippe Labarre, Jacques Mansourati and 12 more

2 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 70 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 10 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02068118 nacompletednot on this map

Optimisation de la Surveillance Ambulatoire Des Insuffisants CArdiaques Par Télécardiologie (OSICAT)

TypeinterventionalSponsorCDM e-HealthRan2013 to 2018Enrolled990ConditionsChronic Heart FailureArmsTelecardiology program
NCT06019169 narecruitingnot on this mapstarted 2024, after this paper: background citation

Randomized Pilot Trial: Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2024 to 2027Enrolled66ConditionsChronic Heart FailureArmsYoga arm, storytelling activities
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 10 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 17 institutions in 3 countries.

Michel GalinierCardiology, Toulouse Rangueil University Hospital (CHU), Toulouse, France.
François RoubillePhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, University Hospital of Montpellier, Montpellier, France.
Philippe BerdagueBeziers Hospital Centre, Beziers, France.
Gilles BrierreIntercommunal Hospital Centre des Vallées de l'Ariege, Foix, France.
Philippe CantieIntercommunal Hospital Centre Castres-Mazamet, Castres, France.
Patrick DaryPrivate Practice, Saint Yrieix La Perche, France.
Jean-Marc FerradouCardiology Aftercare and Rehabilitation Centre, Beaumont de Lomagne, France.
Olivier FondardPasteur Clinic, Toulouse, France.
Jean Philippe LabarrePont de Chaume Clinic, Montauban, France.
Jacques MansouratiCHRU Brest, Brest, France.
François PicardUnité d'Insuffisance Cardiaque, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Jean-Etienne RicciUniversity Hospital of Nimes, Nimes, France.
Muriel SalvatUniversity Hospital of Grenoble, Grenoble, France.
Lamia TartièreLeon Berard Hospital, Hyeres, France.
Jean-Bernard RuidavetsINSERM UMR - U1027, Toulouse, France.
Vanina BongardUSMR - CHU Toulouse, Toulouse, France.
Cécile DelvalAir Liquide Santé International, Loges en Josas, France.
Guila LancmanAir Liquide Santé International, Loges en Josas, France.
Hélène PascheAir Liquide Santé International, Loges en Josas, France.
Juan Fernando Ramirez-GilAir Liquide Santé International, Loges en Josas, France.
Atul PathakDepartment of Cardiovascular Medicine, Princess Grace Hospital, Monaco, Monaco.
OSICAT Investigators
Air Liquide (France) · FRCentre National de la Recherche Scientifique · FRBeaumont Hospital · USCentre Hospitalier de Béziers · FRCentre Hospitalier Intercommunal Castres-Mazamet · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Toulouse · FRClinique du Pont Saint-Vaast · FRClinique Pasteur · FRHôpital Léon Bérard · FRHôpital Sainte-Périne · FRInserm · FRLa Palma Intercommunity Hospital · USPrincess Grace Hospital Centre · MCUniversité de Nîmes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim was to assess the effect of a telemonitoring programme vs. standard care (SC) in preventing all-cause deaths or unplanned hospitalisations in heart failure (HF) at 18 months. METHODS AND

resultsOSICAT was a randomised, multicentre, open-label French study in 937 patients hospitalised for acute HF ≤12 months before inclusion. Patients were randomised to telemonitoring (daily body weight measurement, daily recording of HF symptoms, and personalised education) (n = 482) or to SC (n = 455). Mean ± standard deviation number of events for the primary outcome was 1.30 ± 1.85 for telemonitoring and 1.46 ± 1.98 for SC [rate ratio 0.97, 95% confidence interval (CI) 0.77-1.23; P = 0.80]. In New York Heart Association (NYHA) class III or IV HF, median time to all-cause death or first unplanned hospitalisation was 82 days in the telemonitoring group and 67 days in the SC group (P = 0.03). After adjustment for known predictive factors, telemonitoring was associated with a 21% relative risk reduction in first unplanned hospitalisation for HF [hazard ratio (HR) 0.79, 95% CI 0.62-0.99; P = 0.044); the relative risk reduction was 29% in patients with NYHA class III or IV HF (HR 0.71, 95% CI 0.53-0.95; P = 0.02), 38% in socially isolated patients (HR 0.62, 95% CI 0.39-0.98; P = 0.043), and 37% in patients who were ≥70% adherent to body weight measurement (HR 0.63, 95% CI 0.45-0.88; P = 0.006).

conclusionTelemonitoring did not result in a significantly lower rate of all-cause deaths or unplanned hospitalisations in HF patients. The pre-specified subgroup results suggest the telemonitoring approach improves clinical outcomes in selected populations but need further confirmation.

Indexed as

Heart FailureStandard of CareTelemedicineAgedAged, 80 and overFemaleHospitalizationHumansMaleMiddle AgedBody weightHeart failureHospitalisationPatient educationTelemonitoring

Identifiers

PMID32438483
OpenAlexW3027472286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.